206 related articles for article (PubMed ID: 19366575)
1. Immunogenicity and efficacy of intradermal tattoo immunization with adenoviral vector vaccines.
Potthoff A; Schwannecke S; Nabi G; Hoffmann D; Grunwald T; Wildner O; Brockmeyer NH; Uberla K; Tenbusch M
Vaccine; 2009 May; 27(21):2768-74. PubMed ID: 19366575
[TBL] [Abstract][Full Text] [Related]
2. Intranasal vaccination with a helper-dependent adenoviral vector enhances transgene-specific immune responses in BALB/c mice.
Fu YH; He JS; Zheng XX; Wang XB; Xie C; Shi CX; Zhang M; Tang Q; Wei W; Qu JG; Hong T
Biochem Biophys Res Commun; 2010 Jan; 391(1):857-61. PubMed ID: 19945423
[TBL] [Abstract][Full Text] [Related]
3. Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice.
Guo L; Wang J; Zhou H; Si H; Wang M; Song J; Han B; Shu Y; Ren L; Qu J; Hung T
Vaccine; 2008 Jan; 26(4):460-8. PubMed ID: 18160189
[TBL] [Abstract][Full Text] [Related]
4. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice.
Fu Y; He J; Zheng X; Wu Q; Zhang M; Wang X; Wang Y; Xie C; Tang Q; Wei W; Wang M; Song J; Qu J; Zhang Y; Wang X; Hong T
Biochem Biophys Res Commun; 2009 Apr; 381(4):528-32. PubMed ID: 19233131
[TBL] [Abstract][Full Text] [Related]
5. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
[TBL] [Abstract][Full Text] [Related]
6. Chimpanzee-origin adenovirus vectors as vaccine carriers.
Tatsis N; Tesema L; Robinson ER; Giles-Davis W; McCoy K; Gao GP; Wilson JM; Ertl HC
Gene Ther; 2006 Mar; 13(5):421-9. PubMed ID: 16319951
[TBL] [Abstract][Full Text] [Related]
7. Efficient immunization of rhesus macaques with an HCV candidate vaccine by heterologous priming-boosting with novel adenoviral vectors based on different serotypes.
Fattori E; Zampaglione I; Arcuri M; Meola A; Ercole BB; Cirillo A; Folgori A; Bett A; Cappelletti M; Sporeno E; Cortese R; Nicosia A; Colloca S
Gene Ther; 2006 Jul; 13(14):1088-96. PubMed ID: 16554842
[TBL] [Abstract][Full Text] [Related]
8. Prime-boost immunization using alphavirus replicon and adenovirus vectored vaccines induces enhanced immune responses against classical swine fever virus in mice.
Zhao HP; Sun JF; Li N; Sun Y; Wang Y; Qiu HJ
Vet Immunol Immunopathol; 2009 Oct; 131(3-4):158-66. PubMed ID: 19411115
[TBL] [Abstract][Full Text] [Related]
9. Avian CD154 enhances humoral and cellular immune responses induced by an adenovirus vector-based vaccine in chickens.
Sánchez Ramos O; González Pose A; Gómez-Puerta S; Noda Gomez J; Vega Redondo A; Águila Benites JC; Suárez Amarán L; Parra NC; Toledo Alonso JR
Comp Immunol Microbiol Infect Dis; 2011 May; 34(3):259-65. PubMed ID: 21190734
[TBL] [Abstract][Full Text] [Related]
10. Foot-and-Mouth Disease Virus neutralizing antibodies production induced by pcDNA3 and Sindbis virus based plasmid encoding FMDV P1-2A3C3D in swine.
Dory D; Rémond M; Béven V; Cariolet R; Zientara S; Jestin A
Antiviral Res; 2009 Jul; 83(1):45-52. PubMed ID: 19501256
[TBL] [Abstract][Full Text] [Related]
11. [Immune responses in rhesus induced by recombinant adenovirus Ad-LMP2].
Wang Z; Zhou L; Wu XB; Lu MJ; Xuan YX; Zuo JM; Li F; Wang Q; Ye SQ; Zeng Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):63-5. PubMed ID: 16816867
[TBL] [Abstract][Full Text] [Related]
12. Gag-specific immune enhancement of lentiviral infection after vaccination with an adenoviral vector in an animal model of AIDS.
Klonjkowski B; Klein D; Galea S; Gavard F; Monteil M; Duarte L; Fournier A; Sayon S; Górna K; Ertl R; Cordonnier N; Sonigo P; Eloit M; Richardson J
Vaccine; 2009 Feb; 27(6):928-39. PubMed ID: 19070641
[TBL] [Abstract][Full Text] [Related]
13. Microneedle-mediated immunization of an adenovirus-based malaria vaccine enhances antigen-specific antibody immunity and reduces anti-vector responses compared to the intradermal route.
Carey JB; Vrdoljak A; O'Mahony C; Hill AV; Draper SJ; Moore AC
Sci Rep; 2014 Aug; 4():6154. PubMed ID: 25142082
[TBL] [Abstract][Full Text] [Related]
14. Intradermal DNA vaccination in ear pinnae is an efficient route to protect cats against rabies virus.
Tesoro-Cruz E; Calderón-Rodríguez R; Hernández-González R; Blanco-Favéla F; Aguilar-Setién A
Vet Res; 2008; 39(2):16. PubMed ID: 18215393
[TBL] [Abstract][Full Text] [Related]
15. Preclinical safety and biodistribution of adenovirus-based cancer vaccines after intradermal delivery.
Plog MS; Guyre CA; Roberts BL; Goldberg M; St George JA; Perricone MA
Hum Gene Ther; 2006 Jul; 17(7):705-16. PubMed ID: 16839270
[TBL] [Abstract][Full Text] [Related]
16. Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primates.
Verstrepen BE; Bins AD; Rollier CS; Mooij P; Koopman G; Sheppard NC; Sattentau Q; Wagner R; Wolf H; Schumacher TN; Heeney JL; Haanen JB
Vaccine; 2008 Jun; 26(26):3346-51. PubMed ID: 18467010
[TBL] [Abstract][Full Text] [Related]
17. Recombinant retrovirus-like particle forming DNA vaccines in prime-boost immunization and their use for hepatitis C virus vaccine development.
Desjardins D; Huret C; Dalba C; Kreppel F; Kochanek S; Cosset FL; Tangy F; Klatzmann D; Bellier B
J Gene Med; 2009 Apr; 11(4):313-25. PubMed ID: 19248137
[TBL] [Abstract][Full Text] [Related]
18. Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines.
Tatsis N; Fitzgerald JC; Reyes-Sandoval A; Harris-McCoy KC; Hensley SE; Zhou D; Lin SW; Bian A; Xiang ZQ; Iparraguirre A; Lopez-Camacho C; Wherry EJ; Ertl HC
Blood; 2007 Sep; 110(6):1916-23. PubMed ID: 17510320
[TBL] [Abstract][Full Text] [Related]
19. Mucosal or systemic administration of rE2 glycoprotein antigen loaded PLGA microspheres.
Brandhonneur N; Loizel C; Chevanne F; Wakeley P; Jestin A; Le Potier MF; Le Corre P
Int J Pharm; 2009 May; 373(1-2):16-23. PubMed ID: 19429284
[TBL] [Abstract][Full Text] [Related]
20. Fully detargeted polyethylene glycol-coated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies.
Wortmann A; Vöhringer S; Engler T; Corjon S; Schirmbeck R; Reimann J; Kochanek S; Kreppel F
Mol Ther; 2008 Jan; 16(1):154-62. PubMed ID: 17848961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
